Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Product Launch

RPG Life Sciences Product Launch

RPG Life Sciences partnered with Archerchem Healthcare to launch Naprosyn ES, a Naproxen‑Esomeprazole combo, across India. The product aims to address unmet NSAID therapy needs.

Source

NSE filing, NSE: RPGLIFE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

RPG Life Sciences Ltd: key numbers

Share price
₹2,854.00
Market cap
₹4,720 Cr
Revenue (annual)
₹707.5 Cr
Net profit (annual)
₹115.2 Cr
P/E (TTM)
39.5×Sector 46.5×
Promoter holding
72.95%+0.00% QoQ
FII holding
0.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from RPG Life Sciences Ltd

All →

Other product launch announcements

All →